Provider review
MEDVi review
Writes the stack out in four words: membership plus medication cost.
Two further entry figures appear and nothing reconciles them against that line.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
MEDVi
$99 membership + medication cost, medication unpriced
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
There is an odd honesty to the phrasing here. Most sellers with a membership underneath their medication bury it in a footnote or a terms page; this one prints membership plus medication cost as a single line, repeatedly, which tells you immediately that the number you are looking at is one of two charges. That is the useful part. The unhelpful part is everything around it. Two other figures appear as entry points, both framed as starting prices, and nothing on the page explains how they relate to the membership line — whether they include it, sit on top of it, or describe a different plan altogether. You are therefore told clearly that there are two charges and left unable to work out what either of them actually is, which is a strange place to end up. The medication side, which is the larger of the two in every comparable structure, carries no figure anywhere. If your question is what holding a small dose costs, the answer here is that the membership is quantified and the part that matters is not.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the two-charge structure stated plainly rather than buried in terms
- You want to know the membership component before starting an intake
- You are willing to ask for the medication price directly
Look elsewhere if
- You want a total. The medication carries no figure at all
- You are comparing entry prices. Three appear and none is reconciled with the others
- You want a named molecule and a dose. Neither appears
What it actually costs
Price as published
The published figure is not the bill, and the page says so in the shortest form seen anywhere here — "$99 Membership + Medication Cost", printed three times · so a membership is charged and the medication is charged on top of it, with the medication side carrying no figure at all · separate entry points are advertised at "start for just $179" and "starting at $249", neither of which is reconciled on the page against the membership-plus-medication line, so it is unclear whether those figures are the combined total, the medication alone, or a different plan · that ambiguity is the substance of the row: three numbers appear and the relationship between them is not stated · no molecule is attached to either entry figure and no dose is published · the page reached is a marketing funnel on a subdomain rather than the main site
- Vs median
- Not comparable — the published figure is not the whole bill — a membership, platform fee or separate medication charge sits on top of it
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. The published figure is not the bill and the page says so in four words — a membership charge with medication charged on top — printed three times. Most sellers with this structure bury it in a terms page, so stating it plainly is the useful part. The unhelpful part is that two other entry figures appear and nothing reconciles them against the membership line: whether they include it, sit on top of it, or describe a different plan is never stated. So a reader is told clearly that there are two charges and left unable to work out what either is, with the medication side — the larger one in every comparable structure here — carrying no figure at all. No molecule named, no dose published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Billed separately
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- States the two-charge structure in plain words rather than burying it in terms.
- The membership component is quantified, so half the structure is knowable.
- Entry figures are visible before any intake is started.
Pharmacy, labs and oversight
MEDVi does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is billed separately.
Transparency check
1 of 4 published openly
What MEDVi publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
There is an odd honesty to the phrasing here. Most sellers with a membership underneath their medication bury it in a footnote or a terms page; this one prints membership plus medication cost as a single line, repeatedly, which tells a reader immediately that the number they are looking at is one of two charges. That is the useful part. The unhelpful part is everything around it. Two other figures appear as entry points, both framed as starting prices, and nothing on the page explains how they relate to the membership line — whether they include it, sit on top of it, or describe a different plan altogether. A reader is therefore told clearly that there are two charges and left unable to work out what either of them actually is, which is a strange place to end up. The medication side, which is the larger of the two in every comparable structure on this page, carries no figure anywhere. For a reader whose question is what holding a small dose costs, the answer here is that the membership is ninety-nine dollars and the part that matters is unquantified. No molecule is named against either entry figure and no dose appears behind any of them.
The honest cons
The medication carries no price at all, and it is the larger charge.
- Three figures appear and the relationship between them is never stated.
- No molecule is named against either entry figure, and no dose is published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
MEDVi is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#285 of 373
Ordered with the companies that pay us first, and MEDVi is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.